• Bifendate (DDB): Hepatoprotection, Lipid Regulation & Eviden

  2026-05-04

  Bifendate (DDB), a synthetic Schisandrin C derivative, is a validated hepatoprotection agent that regulates lipid metabolism and inhibits autophagy in liver models. Its efficacy is supported by quantitative evidence in both cell and animal studies, with well-characterized dosing parameters. This article synthesizes current evidence and protocol integration for researchers.

• Arachidonic Acid Supplementation Accelerates Vaccine Immunit

  2026-05-03

  This study demonstrates that dietary arachidonic acid (ARA) supplementation significantly enhances the speed and magnitude of neutralizing antibody responses following rabies vaccination in mice and humans. By elucidating the immunological mechanisms involving PGI2-mediated B cell activation, the research offers a foundation for dietary PUFAs as rapid vaccine adjuvants.

• Plant-Derived Nanovesicles Mitigate Sertoli Cell Cycle Arres

  2026-05-02

  This study demonstrates that exosome-like nanovesicles from Cistanche deserticola (CDELNs) alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The research uncovers a heparan sulfate proteoglycan-mediated uptake mechanism and highlights miRNA-driven regulation of CDK1 activity, offering new avenues for reproductive toxicity intervention.

• Applied Workflows with Recombinant Human IL-15 for Immune As

  2026-05-02

  Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) from APExBIO enables robust, reproducible activation and proliferation of T and NK cells, making it a powerful tool for immunology research. Discover stepwise protocols, performance benchmarks, and troubleshooting strategies to maximize your immune response modulation assays.

• Cy7 NHS Ester: Workflow Guidance for Near-Infrared Protein L

  2026-05-01

  Cy7 NHS ester provides a reliable, water-soluble near-infrared dye for covalent labeling of proteins and peptides via amino groups. It is designed to minimize fluorescence quenching and avoid protein denaturation, making it suitable for in vitro and in vivo imaging workflows. This reagent should not be used for targets lacking accessible primary amines or in systems requiring long-term storage of dye solutions.

• Pazopanib (GW-786034): Multi-Targeted RTK Inhibitor Insights

  2026-04-30

  Pazopanib (GW-786034) is a potent, selective multi-targeted receptor tyrosine kinase inhibitor with validated efficacy in angiogenesis inhibition and tumor growth suppression. Its low nanomolar IC50 for key RTKs and robust oral bioavailability support its utility in advanced cancer research. Benchmarks confirm activity in ATRX-deficient tumor models and synergism with standard chemotherapeutics.

• Filipin III: Reliable Cholesterol Detection for Cell Assays

  2026-04-30

  This article addresses real laboratory challenges in membrane cholesterol visualization using Filipin III (SKU B6034), a polyene macrolide antibiotic from APExBIO. Scenario-driven Q&A blocks provide practical guidance for assay optimization, data interpretation, and vendor selection, grounded in current literature and validated best practices.

• Calpeptin: Precision Calpain Inhibitor for Fibrosis Research

  2026-04-29

  Calpeptin, a nanomolar-potency calpain inhibitor, enables targeted modulation of calcium-dependent cysteine proteases in fibrosis and inflammation models. This article delivers actionable workflows, advanced use-cases, and troubleshooting strategies to maximize the translational impact of Calpeptin in pulmonary fibrosis and extracellular vesicle research.

• MLN4924 HCl Salt: NAE Inhibition, Viral Immunity, and Assay

  2026-04-29

  Explore the advanced science behind MLN4924 HCl salt, a potent NEDD8-activating enzyme inhibitor, and uncover its pivotal role in decoding host-pathogen interactions and optimizing next-generation cell-based assays.

• Pam3CSK4 TFA: A Precision TLR1/2 Agonist for Immune Activati

  2026-04-28

  Pam3CSK4 TFA is a synthetic TLR1/2 agonist optimized for dissecting innate immune responses in both in vitro and in vivo models. Its high purity and robust signaling make it a cornerstone for research into inflammation, cytokine profiling, and translational immunology.

• Cyclophilin A Essential for Cyclosporin A Immunosuppression

  2026-04-28

  This study demonstrates that Cyclophilin A is the principal intracellular target mediating Cyclosporin A’s immunosuppressive activity in vivo. Using gene knockout mouse models, the authors show that Cyclosporin A fails to inhibit T-cell activation or prevent transplant rejection in the absence of Cyclophilin A, refining our understanding of its molecular mechanism and guiding future immunosuppressive research.

• Tamoxifen in Translational Research: Rationale, Validation,

  2026-04-27

  Explore Tamoxifen as a selective estrogen receptor modulator redefining breast cancer research, gene knockout workflows, and mechanistic innovation. This article integrates bench evidence (including recent findings on caveolin-1 modulation), competitive context, and strategic guidance for translational scientists—while highlighting APExBIO’s high-purity Tamoxifen (SKU B5965) as a precision research tool.

• Hyperthermia Enhances PARP Inhibitor Sensitivity in BRCA2-Pr

  2026-04-27

  Mei et al. (2025) demonstrate that hyperthermia-induced reduction of BRCA2 protein sensitizes BRCA2-proficient ovarian carcinoma cells to PARP inhibition. This mechanistic insight suggests a clinically actionable strategy to overcome PARP inhibitor resistance in ovarian cancer using combinatorial hyperthermia and PARP inhibitor approaches.

• ALT Cancer Cells Are Not Universally Hypersensitive to ATR I

  2026-04-26

  This study rigorously tests whether cancer cells using the alternative lengthening of telomeres (ALT) pathway are generally hypersensitive to ATR inhibition. Contrary to previous reports, the authors find no universal hypersensitivity among ALT-positive cell lines, highlighting cell line-specific factors in response to ATR inhibitors and refining therapeutic targeting strategies.

• Lypressin Acetate: Cross-Domain Insights in Endocrine and An

  2026-04-25

  Explore the unique pharmacological properties of Lypressin acetate, a lysine vasopressin analog, and discover its advanced applications in both endocrine and emerging antiviral research. This article delivers new mechanistic depth and practical assay guidance you won't find elsewhere.

445 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page